Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

  • M.P. Coghlan
  • , A.A. Culbert
  • , D.A.E. Cross
  • , S.L. Corcoran
  • , J.W. Yates
  • , N.J. Pearce
  • , O.L. Rausch
  • , G.J. Murphy
  • , P.S. Carter
  • , L.R. Cox
  • , D. Mills
  • , M.J. Brown
  • , David Haigh
  • , R.W. Ward
  • , D.G. Smith
  • , K.J. Murray
  • , A.D. Reith
  • , J.C. Holder

Research output: Contribution to journalArticlepeer-review

837 Citations (Scopus)

Abstract

Background: Glycogen synthase kinase-3 (GSK-8) is a serine/threonine protein kinase, the activity of which is inhibited by a variety of extracellular stimuli including insulin, growth factors, cell specification factors and cell adhesion. Consequently, inhibition of GSK-3 activity has been proposed to play a role in the regulation of numerous signalling pathways that elicit pleiotropic cellular responses. This report describes the identification and characterisation of potent and selective small molecule inhibitors of GSK-3.
Original languageEnglish
Pages (from-to)793-803
Number of pages11
JournalChemistry & Biology
Volume7
Issue number10
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription'. Together they form a unique fingerprint.

Cite this